1. Home
  2. VERV vs HBNC Comparison

VERV vs HBNC Comparison

Compare VERV & HBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERV
  • HBNC
  • Stock Information
  • Founded
  • VERV 2018
  • HBNC 1873
  • Country
  • VERV United States
  • HBNC United States
  • Employees
  • VERV N/A
  • HBNC N/A
  • Industry
  • VERV Medicinal Chemicals and Botanical Products
  • HBNC Major Banks
  • Sector
  • VERV Health Care
  • HBNC Finance
  • Exchange
  • VERV Nasdaq
  • HBNC Nasdaq
  • Market Cap
  • VERV 382.5M
  • HBNC 648.7M
  • IPO Year
  • VERV 2021
  • HBNC N/A
  • Fundamental
  • Price
  • VERV $5.46
  • HBNC $15.87
  • Analyst Decision
  • VERV Strong Buy
  • HBNC Hold
  • Analyst Count
  • VERV 4
  • HBNC 3
  • Target Price
  • VERV $26.00
  • HBNC $15.33
  • AVG Volume (30 Days)
  • VERV 1.2M
  • HBNC 169.0K
  • Earning Date
  • VERV 11-05-2024
  • HBNC 10-23-2024
  • Dividend Yield
  • VERV N/A
  • HBNC 4.10%
  • EPS Growth
  • VERV N/A
  • HBNC N/A
  • EPS
  • VERV N/A
  • HBNC 0.43
  • Revenue
  • VERV $20,648,000.00
  • HBNC $179,998,000.00
  • Revenue This Year
  • VERV $57.08
  • HBNC N/A
  • Revenue Next Year
  • VERV N/A
  • HBNC $7.84
  • P/E Ratio
  • VERV N/A
  • HBNC $36.11
  • Revenue Growth
  • VERV 279.70
  • HBNC N/A
  • 52 Week Low
  • VERV $4.31
  • HBNC $9.22
  • 52 Week High
  • VERV $20.12
  • HBNC $16.64
  • Technical
  • Relative Strength Index (RSI)
  • VERV 57.24
  • HBNC 60.42
  • Support Level
  • VERV $4.37
  • HBNC $14.44
  • Resistance Level
  • VERV $5.86
  • HBNC $16.05
  • Average True Range (ATR)
  • VERV 0.32
  • HBNC 0.40
  • MACD
  • VERV 0.12
  • HBNC 0.11
  • Stochastic Oscillator
  • VERV 73.40
  • HBNC 88.82

About VERV Verve Therapeutics Inc.

Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

Share on Social Networks: